Middle East And Africa Epilepsy Monitoring Devices Market
Taille du marché en milliards USD
TCAC :
% 
 Période de prévision |
2024 –2030 |
 Taille du marché (année de référence) |
|
 Taille du marché (année de prévision) |
Dollars américains 42.13 |
 TCAC |
% |
| Principaux acteurs du marché |
>Marché des dispositifs de surveillance de l'épilepsie au Moyen-Orient et en Afrique, par type de produit (appareils portables, appareils intelligents et appareils conventionnels), type (crises focales et crises généralisées), type de patient (pédiatrique, gériatrique et adulte), utilisateur final (hôpitaux, soins à domicile, centres de neurologie, centres de diagnostic, centres et cliniques de chirurgie ambulatoire , et autres), canal de distribution (ventes au détail, ventes en ligne, appels d'offres directs et autres) - Tendances et prévisions de l'industrie jusqu'en 2030.
Analyse de la taille du marché des dispositifs de surveillance de l'épilepsie au Moyen-Orient et en Afrique
La demande croissante d'appareils portables de surveillance de l'épilepsie contribue à stimuler la croissance globale du marché. Les investissements croissants du gouvernement dans les projets sur l'épilepsie contribuent également à la croissance du marché. Les principaux acteurs du marché se concentrent fortement sur le développement de divers nouveaux appareils de surveillance de l'épilepsie. En outre, la prévalence croissante de l'épilepsie contribue également à la demande croissante du marché.
Le marché des dispositifs de surveillance de l'épilepsie au Moyen-Orient et en Afrique devrait connaître une croissance du marché au cours de la période de prévision de 2023 à 2030. Data Bridge Market Research analyse que le marché croît avec un TCAC de 5,3 % au cours de la période de prévision de 2023 à 2030 et devrait atteindre 42,13 millions USD d'ici 2030.
|
Rapport métrique |
Détails |
|
Période de prévision |
2023 à 2030 |
|
Année de base |
2022 |
|
Année historique |
2021 (personnalisable pour 2020-2015) |
|
Unités quantitatives |
Chiffre d'affaires en millions USD |
|
Segments couverts |
Par type de produit ( appareils portables , appareils intelligents et appareils conventionnels), type (crises focales et crises généralisées), type de patient (pédiatrique, gériatrique et adulte), utilisateur final (hôpitaux, soins à domicile, centres de neurologie, centres de diagnostic, centres et cliniques de chirurgie ambulatoire, et autres), canal de distribution (ventes au détail, ventes en ligne, appels d'offres directs et autres) |
|
Pays couverts |
Afrique du Sud, Émirats arabes unis, Égypte, Arabie saoudite, Koweït, Israël, Bahreïn, Oman, Qatar, reste du Moyen-Orient et de l'Afrique |
|
Acteurs du marché couverts |
NIHON KOHDEN CORPORATION., Masimo, Apple Inc., Natus Medical Incorporated., Owlet, Neurotech, LLC, SmartMonitor et Epilert, entre autres. |
Définition du marché
L'épilepsie est un trouble du système nerveux central (neurologique) dans lequel l'activité cérébrale devient anormale, provoquant des crises ou des périodes de comportement inhabituel, de sensations et parfois de perte de conscience. Les crises d'épilepsie peuvent varier de périodes brèves et presque indétectables à de longues périodes de tremblements vigoureux dus à une activité électrique anormale dans le cerveau. Le type de crise le plus courant est convulsif, qui implique des contractions musculaires involontaires.
Les crises tonico-cloniques se produisent avec une contraction des membres suivie de leur extension et d'une cambrure du dos, qui dure 10 à 30 secondes. Les crises myocloniques impliquent de très brefs spasmes musculaires dans quelques zones ou dans l'ensemble du corps.
Dynamique du marché des dispositifs de surveillance de l'épilepsie au Moyen-Orient et en Afrique
Conducteurs
-
Augmentation de la prévalence de l'épilepsie
Epilepsy is a neurological condition that causes unprovoked, recurrent seizures. A seizure is a sudden rush of abnormal electrical activity in the brain. Doctors diagnose epilepsy when someone has two or more seizures with no other identifiable cause. Anyone can develop epilepsy, but it most commonly onsets in young and older adults. A mild seizure may be difficult to recognize. It may only last a few seconds, and the individual may remain awake while it happens. Stronger seizures can cause spasms and uncontrollable muscle twitches. They can last from a few seconds to several minutes and may cause confusion or loss of consciousness. Afterward, the individual may have no memory of a seizure happening.
Epilepsy has become the world’s most common neurological disorder among every age group. As epilepsy can be treated if diagnosed early, people with epilepsy symptoms are more focused on its diagnosis & treatment by using various technologically advanced monitoring devices. As a result, the demand for epilepsy monitoring devices is increasing & hence, the rising prevalence of epilepsy is driving the growth of the Middle East & Africa epilepsy monitoring devices market.
-
Growing preference for wearable epilepsy monitoring devices
It is a major challenge in clinical epilepsy to diagnose and treat a disease characterized by infrequent seizures based on patient or caregiver reports and limited-duration clinical testing. The poor reliability of self-reported seizure diaries for many people with epilepsy is well-established, but these records remain necessary in clinical care and therapeutic studies.
Several wearable devices have emerged which are capable of detecting seizures, recording seizure data and alerting caregivers. Wearable devices may also facilitate reliable forecasts of seizure likelihood, providing the potential for people with epilepsy to take fast-acting medications or modify activities in anticipation of an impending seizure. Therefore, wearable sensing devices are increasing in popularity both in the general community & through medical applications. Hence, the growing preference for wearable epilepsy monitoring devices is driving the growth of the Middle East & Africa epilepsy monitoring devices market.
-
Rising government investments in the epilepsy project
Epilepsy has become the world’s most common neurological disorder, and so has the mortality rate. Research on the underlying causes of epilepsies, including the identification of genes for some forms of epilepsy, has led to a greatly improved understanding of these disorders that may lead to treatments that are more effective or even to new ways of preventing epilepsy in the future.
Government is more focused on fewer deaths, a better quality of life for patients suffering from epilepsy and fewer seizures. This can be possible with the combination of advanced imaging, cognitive and genetic data, personalized treatment plans and a skilled surgical team where necessary. Hence, the government is investing more in epilepsy projects to enhance the infrastructure and better care for patients. Therefore, it can be a driving factor for the growth of the Middle East & Africa epilepsy monitoring devices market.
Opportunities
-
Rise in technological advancement in the disease monitoring device
With the advent of time, medical devices have undergone various technological changes. The advancement in disease-monitoring medical devices includes using flexible electronics such as thin flaps or skin patches for the accurate and real-time monitoring of vital signs. The validation and accuracy of the recorded data by such devices are also enhanced by the upgradation of new operating software and hardware used in those devices. The advanced flaps-like monitoring system is manufactured by various key market leaders like Neurava, Neuronostics, Epilepsy Alarms and others. Instant and precise assessment of results coupled with the noteworthy existence of these devices due to advancements; escalate the customer preference and adoption rate of such devices. Thus, innovations leading to superior product characteristics and cost-effectivity will spur Middle East & Africa market expansion of epilepsy monitoring devices.
The innovation and advancement in technology have upgraded medical devices in all prospects, including battery life, light weightiness, advanced features like AI assistance, upgraded software, and wireless connectivity, among more. Technological advancement brings many advantages to the patient’s diagnosis and therapeutic uses with improvements in remote monitoring systems. Thus, the increased technological advancement boosts the growth of the Middle East & Africa epilepsy monitoring devices market.
-
Increased demand for the non-invasive and minimally invasive device
An invasive device is a complicated, painful, and risky procedure, as it involves direct intervention with the brain tissue. Therefore, healthcare professionals and patients show a high inclination towards the use of non-invasive and minimally invasive devices. With rising awareness, more patients are opting for minimally invasive or non-invasive procedures. Epilepsy monitoring devices overcome the risks and pain associated with invasive brain monitoring. Many government initiatives also focus on reducing the risks related to treatment options for brain disorders.
Restraints/Challenges
- Poor reimbursement scenario
Reimbursement for all healthcare devices and services has been under downward pressure for several years. These devices also face a major roadblock in their growth due to the lack of reimbursement of these devices. The combination of wearable devices with AI, irrelevant data collection and security issues of medical devices pose a significant impact on these devices that leads to difficulty in a gain of reimbursement for such devices. The reimbursement of a device can significantly affect the ability of a provider to access a particular technology, as well as the willingness of a manufacturer to deliver it. If coverage is uncertain, the manufacturer has difficulty predicting whether an investment in new technology will yield enough returns. This lack of predictability is an apparent barrier to obtaining funding for the company. It further compromises innovation and restricts patient access to advanced technology and solutions.
Monitoring devices have become an important part of healthcare in terms of diagnosis and prognosis of chronic diseases. The increased application of monitoring devices in conditions like neurological, diabetes, obesity and cardiovascular issues, among more, makes it crucial for the healthcare facility. However, the high cost of such devices and the lack of proper reimbursement hampers the adoption rate of these medical devices. Thus, the lack of reimbursement acts as a challenge to the growth of the Middle East & Africa epilepsy monitoring market.
Post-COVID-19 Impact on Middle East & Africa Molecular Diagnostics Services Market
The post-COVID-19 has negatively affected the market. A large number of the population were affected by this pandemic. The supply of ophthalmic products has suffered a massive hit due to the Middle East & Africa pandemic of COVID-19. This reduction in supply is mainly due to various quarantine policies adopted by countries worldwide. This, along with the restrictions of movement and labor reduction, are the major reasons for a decreasing trend in the supply market of medical devices. This has affected the quality and efficacy of medical devices to a high extent. Reduction in the headcount of the labor force due to COVID-19 affliction is another factor contributing to the reduced supply of epilepsy monitoring devices.
Recent Developments
- In December 2022, NIHON KOHDEN CORPORATION announced that it would open a new sale branch of Nihon Kohden Singapore (NKS), one of its sales subsidiaries, aiming to apply for registration of medical devices smoothly and expand its sales in the Philippines
- In February 2022, Masimo announced its entry into a definitive merger agreement to acquire Viper Holdings Corporation, which owns Sound United (“Sound United”). This consumer technology company owns a portfolio of premium brands, including Bowers& Wilkins, Denon, Polk Audio and Marantz. Pursuant to the merger agreement, they had to pay approximately USD 1.025 billion, subject to adjustments, for the acquisition. This helps the organization generate more revenue
Middle East & Africa Epilepsy Monitoring Devices Market Scope
The Middle East & Africa epilepsy monitoring devices market is segmented into five notable segments based on product type, type, patient type, end user and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
By Product Type
- Wearable Devices
- Smart Devices
- Conventional Devices
On the basis of product type, the market is segmented into wearable devices, smart devices and conventional devices.
By Type
- Focal Seizures
- Generalized Seizures
On the basis of type, the market is segmented into focal seizures & generalized seizures.
By Patient Type
- Pediatric
- Geriatric
- Adults
On the basis of patient type, the market is segmented into pediatric, geriatric and adults.
By End User
- Hospitals
- Homecare Setting
- Neurology Centres
- Diagnostic Centres
- Ambulatory Surgical Centres & Clinics
- Others
On the basis of end users, the market is segmented into hospitals, homecare settings, neurology centres, diagnostic centres, ambulatory surgical centres & clinics and others.
By Distribution Channel
- Retail Sales
- Online Sales
- Direct Tenders
- Others
On the basis of distribution channel, the market is segmented into retail sales, online sales, direct tenders and others.
Middle East & Africa Epilepsy Monitoring Devices Market Regional Analysis/Insights
The Middle East & Africa epilepsy monitoring devices market is analyzed, and market size insights and trends are provided by country, product type, type, patient type, end user and distribution channel.
Countries covered in Middle East & Africa epilepsy monitoring devices market are South Africa, U.A.E., Egypt, Saudi Arabia, Kuwait, Israel, Bahrain, Oman, Qatar, Rest of Middle East and Africa.
The South Africa is dominating in Middle East & Africa epilepsy monitoring devices market due to the rise in market players and the availability of various advanced epilepsy monitoring devices in the market. Along with this, the number of government and private collaborations has increased in the market, which is further boosting market growth. However, the high cost associated with complex epilepsy monitoring devices & procedures might hamper the market growth in the forecast period.
La section pays du rapport fournit également des facteurs individuels ayant un impact sur le marché et des changements dans la réglementation du marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que les nouvelles ventes, les ventes de remplacement, la démographie du pays, l'épidémiologie des maladies et les tarifs d'importation et d'exportation sont quelques-uns des principaux indicateurs utilisés pour prévoir le scénario du marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales sur les canaux de vente sont prises en compte lors de l'analyse prévisionnelle des données nationales.
Analyse du paysage concurrentiel et des parts de marché des dispositifs de surveillance de l'épilepsie au Moyen-Orient et en Afrique
Le paysage concurrentiel du marché des dispositifs de surveillance de l'épilepsie au Moyen-Orient et en Afrique fournit des détails par concurrents. Les détails inclus sont un aperçu de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements en R&D, les nouvelles initiatives du marché, la présence au Moyen-Orient et en Afrique, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit et la domination des applications. Les points de données ci-dessus fournis ne concernent que les entreprises qui se concentrent sur le marché.
Certains des principaux acteurs opérant sur le marché des dispositifs de surveillance de l'épilepsie au Moyen-Orient et en Afrique sont NIHON KOHDEN CORPORATION., Masimo, Apple Inc., Natus Medical Incorporated., Owlet, Neurotech, LLC, SmartMonitor et Epilert, entre autres.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
PREMIUM INSIGHTS 92
4.1.1 KEY STRATEGIC INITIATIVES
4.1.2 SEIZURES OCCURRENCE, BY TIME
4.1.2.1 DURING DAY
4.1.2.2 DURING SLEEP
4.1.2.2.1 RAPID EYE MOVEMENT (REM) SLEEP
4.1.2.2.2 NON-REM SLEEP
4.1.2.3 DURING NIGHT
5 EPIDEMIOLOGY
5.1 INCIDENCE & PREVALENCE OF EPILEPSY, BY COUNTRY
5.1.1 GENERALIZED SEIZURES, BY PATIENT TYPE
5.1.1.1 TONIC-CLONIC SEIZURES
5.1.1.2 ABSENCE SEIZURES
5.1.2 FOCAL SEIZURES, BY PATIENT TYPE
5.1.2.1 SIMPLE FOCAL SEIZURES
5.1.2.2 COMPLEX FOCAL SEIZURES
5.1.2.3 SECONDARY GENERALIZED SEIZURES
6 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICE MARKET, REGULATORY FRAMEWORK
6.1 MEDICAL DEVICES
6.2 WEARABLE MEDICAL DEVICES
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING PREVALENCE OF EPILEPSY
7.1.2 GROWING PREFERENCE FOR WEARABLE EPILEPSY MONITORING DEVICES
7.1.3 RISING GOVERNMENT INVESTMENTS IN THE EPILEPSY PROJECT
7.1.4 INCREASED R & D ACTIVITIES IN EPILEPSY
7.2 RESTRAINTS
7.2.1 HIGH COST ASSOCIATED WITH COMPLEX EPILEPSY MONITORING PROCEDURES & DEVICES
7.2.2 PRODUCT RECALL SCENARIO OF EPILEPSY MONITORING DEVICES
7.3 OPPORTUNITIES
7.3.1 RISE IN TECHNOLOGY ADVANCEMENT IN DISEASE MONITORING DEVICE
7.3.2 INCREASED DEMAND FOR NON-INVASIVE AND MINIMALLY INVASIVE DEVICE
7.4 CHALLENGES
7.4.1 POOR REIMBURSEMENT SCENARIO
7.4.2 STRINGENT RULES & REGULATIONS FOR PRODUCT APPROVAL
8 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 WEARABLE DEVICES
8.2.1 SMART WATCHES
8.2.2 OTHER NON-INVASIVE MONITORING DEVICES
8.3 SMART DEVICES
8.3.1 MOTION MONITORS
8.3.2 1.3.2 VIDEO MONITORS
8.3.3 MATTRESS DEVICES
8.3.4 OTHERS
8.4 CONVENTIONAL DEVICES
8.4.1 EEG DEVICE
8.4.1.1 AMBULATORY EEG
8.4.1.2 CONTINUOUS EEG
8.4.1.3 OTHER EEG DEVICES
8.4.2 ELECTROMYOGRAPHY (EMG) DEVICE
8.4.3 ELECTROCARDIOGRAM (ECG) DEVICE
8.4.4 PULSE- OXIMETERS
8.4.5 IMPLANTED ADVISORY SYSTEM
8.4.6 TRIAXIAL ACCELEROMETER (ACM)
8.4.7 MAGNETOMETERS
8.4.8 OTHER DEVICES
9 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY TYPE
9.1 OVERVIEW
9.2 FOCAL SEIZURES
9.2.1 SIMPLE FOCAL SEIZURES
9.2.1.1 SMART DEVICES
9.2.1.2 WEARABLE DEVICES
9.2.1.3 CONVENTIONAL DEVICES
9.2.2 COMPLEX FOCAL SEIZURES
9.2.2.1 SMART DEVICES
9.2.2.2 WEARABLE DEVICES
9.2.2.3 CONVENTIONAL DEVICES
9.2.3 SECONDARY GENERALIZED SEIZURES
9.2.3.1 SMART DEVICES
9.2.3.2 WEARABLE DEVICES
9.2.3.3 CONVENTIONAL DEVICES
9.3 GENERALIZED SEIZURES
9.3.1 TONIC-CLONIC SEIZURES
9.3.1.1 SMART DEVICES
9.3.1.2 WEARABLE DEVICES
9.3.1.3 CONVENTIONAL DEVICES
9.3.2 ABSENCE SEIZURES
9.3.2.1 SMART DEVICES
9.3.2.2 WEARABLE DEVICES
9.3.2.3 CONVENTIONAL DEVICES
10 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE
10.1 OVERVIEW
10.2 PEDIATRIC
10.3 GERIATRIC
10.4 ADULTS
11 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 HOMECARE SETTINGS
11.4 NEUROLOGY CENTRES
11.5 DIAGNOSTIC CENTRES
11.6 AMBULATORY SURGICAL CENTRES AND CLINICS
11.7 OTHERS
12 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 RETAIL SALES
12.3 ONLINE SALES
12.4 DIRECT TENDERS
12.5 OTHERS
13 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY REGION
13.1 MIDDLE EAST AND AFRICA
13.1.1 SOUTH AFRICA
13.1.2 UAE
13.1.3 EGYPT
13.1.4 SAUDI ARABIA
13.1.5 KUWAIT
13.1.6 ISRAEL
13.1.7 BAHRAIN
13.1.8 OMAN
13.1.9 QATAR
13.1.10 REST OF MIDDLE EAST AND AFRICA
14 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
15 SWOT
16 COMPANY PROFILES
16.1 NIHON KOHDEN CORPORATION.
16.1.1 COMPANY SNAPSHOT
16.1.2 RECENT FINANCIALS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 MASIMO
16.2.1 COMPANY SNAPSHOT
16.2.2 RECENT FINANCIALS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 APPLE INC.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 NATUS MEDICAL INCORPORATED.
16.4.1 COMPANY SNAPSHOT
16.4.2 RECENT FINANCIALS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 OWLET.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENT
16.6 ACTIGRAPH, LLC.
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 ADVANCED BRAIN MONITORING, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 CAPTUREPROFF INC.
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 EMPATICA INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 EPIHUNTER
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENT
16.11 EPILERT
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 EPILEPSY ALARMS UK
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 EPI USA.
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 EPIVIEW
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 FREQUENCY PRECISION.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 HIPASS DESIGN LLC
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 IBABY LABS, INC.
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENT
16.18 ITS DESIGNS LTD
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 LIVASSURED
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 LIVELIFE ALARMS.
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 MEDPAGE LTD
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 MIKU INC.
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENT
16.23 NEUROSOFT
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENTS
16.24 NEUROTECH, LLC
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT DEVELOPMENT
16.25 SAFE-LIFE
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENT
16.26 SMARTMONITOR
16.26.1 COMPANY SNAPSHOT
16.26.2 PRODUCT PORTFOLIO
16.26.3 RECENT DEVELOPMENT
16.27 SNUZA
16.27.1 COMPANY SNAPSHOT
16.27.2 PRODUCT PORTFOLIO
16.27.3 RECENT DEVELOPMENT
16.28 THE ‘LIFE MINDER’
16.28.1 COMPANY SNAPSHOT
16.28.2 PRODUCT PORTFOLIO
16.28.3 RECENT DEVELOPMENT
16.29 VAHLKAMP INTERNATIONAL B.V.
16.29.1 COMPANY SNAPSHOT
16.29.2 PRODUCT PORTFOLIO
16.29.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
Liste des tableaux
TABLE 1 REGULATORY APPROVAL CONSIDERATIONS IN WEARABLE MEDICAL DEVICES (WMDS)
TABLE 2 REGULATORY APPROVAL CONSIDERATIONS IN WEARABLE MEDICAL DEVICES (WMDS)
TABLE 3 REGULATORY APPROVAL CONSIDERATIONS IN WEARABLE MEDICAL DEVICES (WMDS)
TABLE 4 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION))
TABLE 21 MIDDLE EAST & AFRICA ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA PEDIATRIC IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA GERIATRIC IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA ADULTS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA HOSPITALS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA HOMECARE SETTINGS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA NEUROLOGY CENTERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA DIAGNOSTIC CENTERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTRES AND CLINIC IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA OTHERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA RETAIL SALES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA ONLINE SALES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA DIRECT TENDERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA OTHERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 42 MIDDLE EAST AND AFRICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 43 MIDDLE EAST AND AFRICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 45 MIDDLE EAST AND AFRICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 46 MIDDLE EAST AND AFRICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 48 MIDDLE EAST AND AFRICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 49 MIDDLE EAST AND AFRICA EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 50 MIDDLE EAST AND AFRICA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 51 MIDDLE EAST AND AFRICA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 52 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 53 MIDDLE EAST AND AFRICA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 54 MIDDLE EAST AND AFRICA SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 55 MIDDLE EAST AND AFRICA COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 56 MIDDLE EAST AND AFRICA SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 57 MIDDLE EAST AND AFRICA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 58 MIDDLE EAST AND AFRICA TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 59 MIDDLE EAST AND AFRICA ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 60 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 61 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 62 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 63 SOUTH AFRICA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 SOUTH AFRICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 65 SOUTH AFRICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 66 SOUTH AFRICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 67 SOUTH AFRICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 68 SOUTH AFRICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 69 SOUTH AFRICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 70 SOUTH AFRICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 71 SOUTH AFRICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 72 SOUTH AFRICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 73 SOUTH AFRICA EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 74 SOUTH AFRICA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 75 SOUTH AFRICA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 76 SOUTH AFRICA EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 77 SOUTH AFRICA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 78 SOUTH AFRICA SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 79 SOUTH AFRICA COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 80 SOUTH AFRICA SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 81 SOUTH AFRICA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 82 SOUTH AFRICA TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 83 SOUTH AFRICA ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 84 SOUTH AFRICA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 85 SOUTH AFRICA EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 86 SOUTH AFRICA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 87 U.A.E EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 88 U.A.E WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 89 U.A.E WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 90 U.A.E WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 91 U.A.E SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 92 U.A.E SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 93 U.A.E SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 94 U.A.E CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 95 U.A.E CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 96 U.A.E CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 97 U.A.E EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 98 U.A.E EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 99 U.A.E EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 100 U.A.E EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 101 U.A.E FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 102 U.A.E SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 103 U.A.E COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 104 U.A.E SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 105 U.A.E GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 106 U.A.E TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 107 U.A.E ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 108 U.A.E EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 109 U.A.E EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 110 U.A.E EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 111 EGYPT EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 112 EGYPT WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 113 EGYPT WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 114 EGYPT WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 115 EGYPT SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 116 EGYPT SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 117 EGYPT SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 118 EGYPT CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 119 EGYPT CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 120 EGYPT CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 121 EGYPT EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 122 EGYPT EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 123 EGYPT EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 124 EGYPT EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 125 EGYPT FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 126 EGYPT SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 127 EGYPT COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 128 EGYPT SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 129 EGYPT GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 130 EGYPT TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 131 EGYPT ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 132 EGYPT EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 133 EGYPT EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 134 EGYPT EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 135 SAUDI ARABIA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 136 SAUDI ARABIA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 137 SAUDI ARABIA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 138 SAUDI ARABIA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 139 SAUDI ARABIA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 140 SAUDI ARABIA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 141 SAUDI ARABIA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 142 SAUDI ARABIA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 143 SAUDI ARABIA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 144 SAUDI ARABIA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 145 SAUDI ARABIA EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 146 SAUDI ARABIA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 147 SAUDI ARABIA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 148 SAUDI ARABIA EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 149 SAUDI ARABIA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 150 SAUDI ARABIA SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 151 SAUDI ARABIA COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 152 SAUDI ARABIA SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 153 SAUDI ARABIA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 154 SAUDI ARABIA TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 155 SAUDI ARABIA ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 156 SAUDI ARABIA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 157 SAUDI ARABIA EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 158 SAUDI ARABIA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 159 KUWAIT EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 160 KUWAIT WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 161 KUWAIT WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 162 KUWAIT WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 163 KUWAIT SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 164 KUWAIT SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 165 KUWAIT SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 166 KUWAIT CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 167 KUWAIT CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 168 KUWAIT CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 169 KUWAIT EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 170 KUWAIT EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 171 KUWAIT EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 172 KUWAIT EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 173 KUWAIT FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 174 KUWAIT SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 175 KUWAIT COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 176 KUWAIT SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 177 KUWAIT GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 178 KUWAIT TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 179 KUWAIT ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 180 KUWAIT EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 181 KUWAIT EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 182 KUWAIT EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 183 ISRAEL EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 184 ISRAEL WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 185 ISRAEL WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 186 ISRAEL WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 187 ISRAEL SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 188 ISRAEL SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 189 ISRAEL SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 190 ISRAEL CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 191 ISRAEL CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 192 ISRAEL CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 193 ISRAEL EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 194 ISRAEL EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 195 ISRAEL EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 196 ISRAEL EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 197 ISRAEL FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 198 ISRAEL SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 199 ISRAEL COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 200 ISRAEL SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 201 ISRAEL GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 202 ISRAEL TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 203 ISRAEL ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 204 ISRAEL EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 205 ISRAEL EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 206 ISRAEL EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 207 BAHRAIN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 208 BAHRAIN WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 209 BAHRAIN WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 210 BAHRAIN WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 211 BAHRAIN SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 212 BAHRAIN SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 213 BAHRAIN SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 214 BAHRAIN CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 215 BAHRAIN CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 216 BAHRAIN CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 217 BAHRAIN EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 218 BAHRAIN EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 219 BAHRAIN EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 220 BAHRAIN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 221 BAHRAIN FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 222 BAHRAIN SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 223 BAHRAIN COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 224 BAHRAIN SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 225 BAHRAIN GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 226 BAHRAIN TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 227 BAHRAIN ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 228 BAHRAIN EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 229 BAHRAIN EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 230 BAHRAIN EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 231 OMAN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 232 OMAN WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 233 OMAN WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 234 OMAN WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 235 OMAN SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 236 OMAN SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 237 OMAN SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 238 OMAN CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 239 OMAN CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 240 OMAN CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 241 OMAN EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 242 OMAN EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 243 OMAN EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 244 OMAN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 245 OMAN FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 246 OMAN SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 247 OMAN COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 248 OMAN SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 249 OMAN GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 250 OMAN TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 251 OMAN ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 252 OMAN EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 253 OMAN EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 254 OMAN EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 255 QATAR EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 256 QATAR WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 257 QATAR WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 258 QATAR WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 259 QATAR SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 260 QATAR SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 261 QATAR SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 262 QATAR CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 263 QATAR CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 264 QATAR CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 265 QATAR EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 266 QATAR EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 267 QATAR EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 268 QATAR EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 269 QATAR FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 270 QATAR SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 271 QATAR COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 272 QATAR SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 273 QATAR GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 274 QATAR TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 275 QATAR ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 276 QATAR EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 277 QATAR EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 278 QATAR EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 279 REST OF MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
Liste des figures
FIGURE 1 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: DBMR POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: END USER COVERAGE GRID
FIGURE 10 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: SEGMENTATION
FIGURE 11 THE RISING PREVALENCE OF EPILEPSY & GROWING PREFERENCE FOR WEARABLE EPILEPSY MONITORING DEVICES ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET FROM 2023 TO 2030
FIGURE 12 THE WEARABLE DEVICE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET FROM 2023 TO 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET
FIGURE 14 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE, 2022
FIGURE 15 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY TYPE, 2022
FIGURE 19 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY TYPE, 2023-2030 (USD MILLION)
FIGURE 20 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 21 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE, 2022
FIGURE 23 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE 2023-2030 (USD MILLION)
FIGURE 24 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE, CAGR (2023-2030)
FIGURE 25 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE, LIFELINE CURVE
FIGURE 26 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY END USER, 2022
FIGURE 27 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET: SNAPSHOT (2022)
FIGURE 35 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022)
FIGURE 36 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET: PRODUCT TYPE (2023-2030)
FIGURE 39 MIDDLE EAST & AFRICA EPILEPSY MONITORING DEVICES MARKET: COMPANY SHARE 2022 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
